BANCO SANTANDER BRASIL-ADS (BSBR)

US05967A1079 - ADR

5.13  -0.14 (-2.66%)

After market: 5.13 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BSBR. BSBR was compared to 411 industry peers in the Banks industry. BSBR has a bad profitability rating. Also its financial health evaluation is rather negative. BSBR is valued expensive and it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

In the past year BSBR was profitable.
BSBR had a positive operating cash flow in the past year.
In the past 5 years BSBR has always been profitable.
BSBR had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of BSBR (0.85%) is comparable to the rest of the industry.
BSBR has a Return On Equity of 8.26%. This is comparable to the rest of the industry: BSBR outperforms 41.12% of its industry peers.
Industry RankSector Rank
ROA 0.85%
ROE 8.26%
ROIC N/A
ROA(3y)1.32%
ROA(5y)1.51%
ROE(3y)11.97%
ROE(5y)13.12%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BSBR's Profit Margin of 12.08% is on the low side compared to the rest of the industry. BSBR is outperformed by 84.91% of its industry peers.
BSBR's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for BSBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 12.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.34%
PM growth 5Y-9.67%
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The number of shares outstanding for BSBR remains at a similar level compared to 1 year ago.
BSBR has less shares outstanding than it did 5 years ago.
BSBR has a worse debt/assets ratio than last year.

2.2 Solvency

BSBR has a debt to FCF ratio of 7.10. This is a slightly negative value and a sign of low solvency as BSBR would need 7.10 years to pay back of all of its debts.
BSBR's Debt to FCF ratio of 7.10 is on the low side compared to the rest of the industry. BSBR is outperformed by 74.70% of its industry peers.
BSBR has a Debt/Equity ratio of 2.27. This is a high value indicating a heavy dependency on external financing.
BSBR has a Debt to Equity ratio of 2.27. This is amonst the worse of the industry: BSBR underperforms 92.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.27
Debt/FCF 7.1
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

1

3. Growth

3.1 Past

The earnings per share for BSBR have decreased strongly by -34.00% in the last year.
BSBR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.47% yearly.
Looking at the last year, BSBR shows a very negative growth in Revenue. The Revenue has decreased by -13.63% in the last year.
BSBR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.54% yearly.
EPS 1Y (TTM)-34%
EPS 3Y-11.02%
EPS 5Y-5.47%
EPS growth Q2Q-29.87%
Revenue 1Y (TTM)-13.63%
Revenue growth 3Y0.35%
Revenue growth 5Y4.54%
Revenue growth Q2Q32.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.52, BSBR is valued on the expensive side.
86.62% of the companies in the same industry are cheaper than BSBR, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.20, BSBR is valued at the same level.
Industry RankSector Rank
PE 20.52
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BSBR indicates a rather cheap valuation: BSBR is cheaper than 85.40% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.37
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

BSBR has a Yearly Dividend Yield of 1.23%.
Compared to an average industry Dividend Yield of 3.86, BSBR's dividend is way lower than its industry peers. On top of this 82.97% of the companies listed in the same industry pay a better dividend than BSBR!
With a Dividend Yield of 1.23, BSBR pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.23%

5.2 History

On average, the dividend of BSBR grows each year by 25.45%, which is quite nice.
BSBR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)25.45%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A

BANCO SANTANDER BRASIL-ADS

NYSE:BSBR (4/25/2024, 7:04:01 PM)

After market: 5.13 0 (0%)

5.13

-0.14 (-2.66%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap38.33B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.23%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.52
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 8.26%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 12.08%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 2.27
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-34%
EPS 3Y-11.02%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.63%
Revenue growth 3Y0.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y